| Systematic (IUPAC) name | |
|---|---|
| methyl (1R,2S,3S,5S)-8-methyl-3-phenyl -8-azabicyclo[3.2.1]octane-2-carboxylate | |
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | ? (UK) |
| Identifiers | |
| CAS number | 74163-84-1 |
| ATC code | None |
| PubChem | CID 170832 |
| ChEMBL | CHEMBL298684 |
| Chemical data | |
| Formula | C16H21NO2 |
| Mol. mass | 259.343 g/mol |
| SMILES | eMolecules & PubChem |
| Physical data | |
| Melt. point | 190–191 °C (374–376 °F) |
| |
|
(–)-2β-Carbomethoxy-3β-phenyltropane (Troparil, WIN 35,065-2, β-CPT) is a stimulant drug used in scientific research. CPT is a phenyltropane based dopamine reuptake inhibitor (DRI) and is derived from methylecgonidine. Troparil is documented to be a few times more potent than cocaine as a dopamine reuptake inhibitor,[1] but is less potent as a serotonin reuptake inhibitor,[2] and has a duration spanning a few times longer, since the phenyl ring is directly connected to tropane through a non-hydrolyzable carbon-carbon bond. The lack of an ester linkage removes the local anesthetic action from the drug, so CPT is a pure stimulant. This change in activity also makes CPT slightly less cardiotoxic than cocaine.[3] The most commonly used form of β-CPT is the tartrate salt, but the hydrochloride and naphthalenedisulfonate salts are also available, as well as the free base.
|
Contents
|
The first known published synthesis of WIN 35,065-2 and WIN 35,428 is by Clarke and co-workers during the 1970s.[4][5] Apparently it was their intention to separate the stimulant actions of cocaine from its toxicity and dependence liability. Troparil is the only regular phenyltropane having a NET affinity that exceeds the DAT affinity.
Phenyltropanes are likely to have less abuse and dependency compared with cocaine.[6][7]
CPT is used in scientific research into the dopamine reuptake transporter. 3H-radiolabelled forms of CPT have been used in humans and animals to map the distribution of dopamine transporters in the brain.[8][9] It is also used for animal research into stimulant drugs as an alternative to cocaine which produces similar effects,[10] but avoids the stringent licensing requirements for the use of cocaine itself.
β-CPT has similar effects to cocaine in animal studies,[11][12] but recreational use of this compound to date has proven extremely rare. Despite being easily made by the reaction of methylecgonidine with phenylmagnesium bromide,[5][13] the relative scarcity of methylecgonidine and the demanding reaction conditions required for the synthesis[14][15] put production of this compound beyond the capacity of most illicit drug manufacturers, and legitimate supplies of β-CPT are available only in very small quantities for a very high price.
The legal status of CPT is unclear. Sigma-Aldrich claims that it is a Schedule II / Class B drug in the USA and UK,[16] but it is not listed in any controlled drugs legislation or published lists of illegal drugs from the relevant government departments in these jurisdictions. Nevertheless, CPT may be considered a controlled substance analogue of cocaine on the grounds of its related chemical structure in some jurisdictions such as Australia and New Zealand.
This is somewhat unclear as there has not been any legal precedent set to determine whether a compound derived by the simplification of an illegal drug molecule (removal of an ester link in this instance) can be considered "substantially similar" to the illegal drug; all previous examples of designer drugs such as α-methylfentanyl have been derived instead by adding extra substituent groups onto the molecule, and the laws covering this area only refer to the addition or substitution of groups onto the illegal drug molecule, not their removal. An excessively broad precedent set in this area would be extremely problematic from a legal standpoint.
|
|||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)